Last reviewed:December 2019
Last updated:January  2018

Summary

Definition

History and exam

Key diagnostic factors

  • hx of known gene mutation
  • use of drugs or circumstances known to increase the QT interval
  • syncope during heightened adrenergic tone
  • syncope during arousal or surprise
  • arrhythmic symptoms post partum
  • syncope at rest and during bradycardia
  • cardiac syncope
  • palpitations
  • periodic paralysis
  • dysmorphic features
  • sensorineural deafness

Other diagnostic factors

  • dizziness
  • angina
  • fatigue
  • oliguria
  • muscle weakness
  • tetany
  • numbness
  • Chvostek's sign
  • Trousseau's sign
  • cold and pale extremities
  • hypotension
  • confusion

Risk factors

  • KCNQ1 gene mutations
  • KCNH2 gene mutations
  • SCN5A gene mutations
  • QT interval-prolonging drugs
  • hypokalaemia
  • hypomagnesaemia
  • hypocalcaemia
  • bradyarrhythmias
  • CNS lesions
  • female sex
  • malnutrition

Diagnostic investigations

Treatment algorithm

Contributors

Associate Professor of Medicine

University of Rochester Medical Center

Rochester

NY

Disclosures

MKA declares that he has no competing interests.

Director

Electrophysiology Service

Professor of Medicine

Duke University Medical Center

Duke Clinical Research Institute

Durham

NC

Disclosures

JPD is a consultant for the American College of Cardiology, ARCA Biopharma, Biosense Webster, Biotronik, Boston Scientific, Cardiofocus, Gilead Sciences Inc., Medtronic Inc., NIH-NHLBi, Northwestern University, Orexigen Therapeutics Inc., St. Jude, and Vytronus.

Peer reviewersVIEW ALL

Director of Cardiac Hospitalization

Department of Cardiology

Tel Aviv Medical Center

Tel Aviv

Israel

Disclosures

SV declares that he has no competing interests.

Associate Professor

Heart and Vascular Center

MetroHealth Campus

Case Western Reserve University

Cleveland

OH

Disclosures

ESK declares that she has no competing interests.

Use of this content is subject to our disclaimer